Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Trial with Meclizine in Hepatocellular Carcinoma

NCT03253289 is registered in ClinicalTrials.gov with Tannaz Armaghnay as lead sponsor.

NCT NCT03253289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Trial with Meclizine in Hepatocellular Carcinoma
Lead sponsor
Tannaz Armaghnay
Phase
Phase 1
Overall status
Completed
Start date
October 13, 2017
Completion date
March 28, 2023
Enrollment
13 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular